Simplex Trading’s Foghorn Therapeutics FHTX Stock Holding History

Simplex Trading’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-700	Closed	-$3.78K	–	9399
2025 Q4	$3.78K	Buy	+700	New	+$3.17K	﹤0.01%	7569
2025 Q3	–	Sell	-400	Closed	-$1K	–	9347
2025 Q2	$1K	Sell	400 -500	-56%	-$2.09K	﹤0.01%	8313
2025 Q1	$3K	Buy	+900	New	+$4.1K	﹤0.01%	7806
2024 Q2	–	Sell	-200	Closed	-$1K	–	9075
2024 Q1	$1K	Buy	+200	New	+$1.11K	﹤0.01%	8560
2022 Q4	–	Sell	-200	Closed	-$1K	–	9532
2022 Q3	$1K	Buy	+200	New	+$2.57K	﹤0.01%	9528
2022 Q2	–	Sell	-500	Closed	-$7K	–	10286
2022 Q1	$7K	Sell	500 -62,200	-99%	-$854K	﹤0.01%	9161
2021 Q4	$1.43M	Buy	+62,700	New	+$901K	﹤0.01%	2407

Other funds holding FHTX

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Simplex Trading's FHTX Position: Q2 2026 in Review

Simplex Trading increased its Foghorn Therapeutics (FHTX) stake by 2,767% in Q2 2026, buying an estimated $8.1K and bringing the position to 1,892 shares worth $9.23K. The position accounts for ﹤0.01% of the portfolio, ranked #7752.

Simplex Trading first reported a position in FHTX in Q4 2021 and has held it in 9 quarters since. The position peaked at $126K in Q4 2021. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

Simplex Trading held 1,892 shares of Foghorn Therapeutics worth $9.23K as of Q2 2026.
Simplex Trading bought 1,826 Foghorn Therapeutics shares in Q2 2026, an estimated $8.1K.
Foghorn Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7752 holding.
Simplex Trading first reported a position in Foghorn Therapeutics in Q4 2021 and has held it in 9 quarters since.
Simplex Trading's Foghorn Therapeutics position peaked at $126K in Q4 2021.
103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.